Evaluation of an NCCN guideline-based weight management pathway on weight loss in female breast cancer patients.

Authors

Damien Hansra

Damien Mikael Hansra

Cancer Treatment Centers of America, Atlanta, GA

Damien Mikael Hansra, Eugene R Ahn, Nathan Schoeber, Jennifer Cargile, Anita Johnson, Ricardo H. Alvarez

Organizations

Cancer Treatment Centers of America, Atlanta, GA, Cancer Treatment Centers of America, Zion, IL, Cancer Treatment Centers of America Atlanta, Newnan, GA, Cancer Treatment Centers of America, Newnan, GA

Research Funding

Other
Cancer Treatment Centers of America.

Background: Obesity is a risk factor for many breast cancer (BC) subtypes & is associated w/ inferior BC outcomes. Here, we investigate the effect of a NCCN based intervention on weight loss (WL) in BC pts. Methods: Prospective study using WL guidelines adapted from NCCN Survivorship (V. 2.2017). Data collected: demographics, clinical, cardiovascular risk factors (CVD), weight, height, body fat%. Stats: 1 sample T-Test w/ 2 tail p-value & 95% CI used to calculate change in weight from baseline to 3 & 6 months (mo) using hypothetical mean of 0. Inclusions: Female BC pts, stage 0-III, OW (BMI > 25mg/m2) or OB (BMI > 30kg/m2). Exclusions: No BC, stage IV, not OW/OB, lost to follow up (f/u), non-compliance, death, or recurrent disease. Intervention: BMI assessed at baseline at initial visit where pt received 20 minute OB counseling by oncologist (ONC). Pts include NEW pts (treatment & surgery naïve) & F/U pts (pts finished definitive treatment in survivorship). ONC counseling included pt education on OB & cancer outcomes & CVD risk. Initially, pts referred to physical therapy (PT) for exercise program & dietician (DT) for nutrition counseling. Pts visit PT & DT q 3 mo. ONC counseling provided periodically during scheduled visits. Results: 70 pts enrolled 10/26/2017 – 10/8/2018. Median pt age = 56 yrs (37-87). Menopausal status: 25/70 (36%) pre menopause vs. 45/70 (64%) post menopause. Race: 29/70 Caucasian (41%), 41/70 (59%) African American, 0/70 (0%) other. Ethnicity: 2/70 (3%) Latin vs. 68/70 (97%) non-Latin. Avg. BMI = 34 kg/m2 (26-54). Avg. weight = 90 kg (61-143). Stage: 0 = 7/70 (10%) , I = 26/70 (37%), II = 21/70 (30%), III = 16/70 (23%). Receptors: 12/70 (17%) triple negative, 13/70 (19%) Her-2+, 49/70 (70%) ER/PR+. CVD risk factors & body fat% shown separately. Mean WL for the 70 pts (NEW + F/U, N = 70) = -0.7 kg @ 3 mo. (p = 0.08), 95%CI (-1.510- +0.101); mean WL = -0.7 kg @ 6 mo. (p = 0.16), 95%CI (-1.703-+0.295). Mean WL for NEW pts, (N = 52) lost -0.9 kg @ 3 mo. (p = 0.0467), 95%CI (-1.809- -0.014). New pts lost -0.7 kg @ 6 mo. (p = 0.21), 95% CI (-1.868 - +0.440). Conclusions: Implementation of the NCCN guidelines + ONC counseling as part of a WL program mitigates weight gain @ 3 & 6 mo in all OW & OB BC pts & induced significant weight loss in NEW pts @ 3 mo.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2019 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session B: Patient Experience; Safety; Technology and Innovation in Quality of Care

Track

Patient Experience,Technology and Innovation in Quality of Care,Safety

Sub Track

Use of Clinical Pathways

Citation

J Clin Oncol 37, 2019 (suppl 27; abstr 301)

DOI

10.1200/JCO.2019.37.27_suppl.301

Abstract #

301

Poster Bd #

L2

Abstract Disclosures

Similar Abstracts

First Author: Megan A Mullins

First Author: Lisa Mikesell

Abstract

2023 ASCO Annual Meeting

Risk factors of early liver metastasis in patients with breast cancer.

First Author: Minxue Zhu